Voloridge Investment Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $165,268 - $211,271	-12,170 Reduced 6.27%	182,059 $2.86 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $1.96 Million - $3.21 Million	194,229 New	194,229 $3.13 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $737,287 - $945,316	-49,649 Reduced 17.52%	233,699 $3.83 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $901,140 - $1.47 Million	-72,790 Reduced 20.44%	283,348 $5.24 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $2.38 Million - $3.65 Million	-260,735 Reduced 42.27%	356,138 $4.68 Million
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $1.19 Million - $1.92 Million	173,111 Added 39.01%	616,873 $5.72 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $3.42 Million - $16.5 Million	443,762 New	443,762 $4.34 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $1.09 Million - $2.24 Million	-32,263 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $114,405 - $252,377	3,609 Added 12.6%	32,263 $2.01 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $571,647 - $1.11 Million	28,654 New	28,654 $973,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.